What does CUSIP 800677106 represent in this 13F holders report?

CUSIP 800677106 is the security identifier for SGMO - SANGAMO THERAPEUTICS, INC - Common Stock used to aggregate holder disclosures.

How many institutions held SGMO - SANGAMO THERAPEUTICS, INC - Common Stock in Q2 2020?

197 institutional investors reported SGMO - SANGAMO THERAPEUTICS, INC - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

SANGAMO THERAPEUTICS, INC - Common Stock (SGMO)

CUSIP: 800677106

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 294,683,714
Total 13F shares: 77,064,448
Share change: +2,682,541
Total reported value: $690,282,893
Put/Call ratio: 76%
Price per share: $8.96
Number of holders: 197
Value change: +$38,360,714
Number of buys: 103
Number of sells: 56

Quarterly Holders Quick Answers

What is CUSIP 800677106?
CUSIP 800677106 identifies SGMO - SANGAMO THERAPEUTICS, INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 800677106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SGMO - SANGAMO THERAPEUTICS, INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	3.2%	9,377,336	$59,735,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	2.9%	8,554,638	$54,493,000	—	31 Mar 2020	13F
WASATCH ADVISORS LP	13F	Company	2%	5,938,434	$37,828,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	1.6%	4,847,768	$30,880,000	—	31 Mar 2020	13F
Bellevue Group AG	13F	Company	1.3%	3,850,000	$24,525,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	0.94%	2,756,610	$17,560,000	—	31 Mar 2020	13F
EcoR1 Capital, LLC	13F	Company	0.78%	2,308,079	$14,702,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.75%	2,196,935	$13,995,000	—	31 Mar 2020	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.69%	2,032,980	$12,950,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.57%	1,689,025	$10,759,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.51%	1,490,819	$9,496,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.5%	1,488,020	$9,479,000	—	31 Mar 2020	13F
Casdin Capital, LLC	13F	Company	0.49%	1,455,000	$9,268,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	0.49%	1,453,042	$9,256,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.47%	1,395,696	$8,891,000	—	31 Mar 2020	13F
MARSHALL WACE, LLP	13F	Company	0.46%	1,363,039	$8,683,000	—	31 Mar 2020	13F
Alexandria Capital, LLC	13F	Company	0.34%	1,005,119	$6,403,000	—	31 Mar 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	0.34%	999,823	$6,369,000	—	31 Mar 2020	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.32%	954,853	$6,082,000	—	31 Mar 2020	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.32%	947,804	$6,038,000	—	31 Mar 2020	13F
FMR LLC	13F	Company	0.28%	828,127	$5,275,000	—	31 Mar 2020	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.26%	762,655	$4,858,113	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.25%	727,490	$4,635,000	—	31 Mar 2020	13F
Rhenman & Partners Asset Management AB	13F	Company	0.24%	700,000	$4,459,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.23%	677,266	$4,314,000	—	31 Mar 2020	13F
Hudson Bay Capital Management LP	13F	Company	0.23%	675,000	$4,300,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.23%	669,137	$4,262,000	—	31 Mar 2020	13F
S.c.a. Candriam	13F	Individual	0.18%	520,000	$4,255,000	—	31 Mar 2020	13F
GREAT POINT PARTNERS LLC	13F	Company	0.21%	633,505	$4,035,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.21%	622,894	$3,968,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.17%	514,645	$3,278,000	—	31 Mar 2020	13F
BAILARD, INC.	13F	Company	0.15%	451,000	$2,873,000	—	31 Mar 2020	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.15%	432,906	$2,758,000	—	31 Mar 2020	13F
ALTRINSIC GLOBAL ADVISORS LLC	13F	Company	0.14%	416,500	$2,653,000	—	31 Mar 2020	13F
MACQUARIE GROUP LTD	13F	Company	0.14%	400,000	$2,548,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	0.13%	395,329	$2,518,000	—	31 Mar 2020	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.12%	362,761	$2,311,000	—	31 Mar 2020	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.11%	324,506	$2,106,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.1%	300,655	$1,915,000	—	31 Mar 2020	13F
Marshall Wace North America L.P.	13F	Company	0.09%	266,684	$1,698,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	0.09%	265,413	$1,691,000	—	31 Mar 2020	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.08%	245,840	$1,566,000	—	31 Mar 2020	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.08%	243,672	$1,552,000	—	31 Mar 2020	13F
CITIGROUP INC	13F	Company	0.08%	238,979	$1,523,000	—	31 Mar 2020	13F
Senvest Management, LLC	13F	Company	0.08%	235,000	$1,497,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.08%	234,200	$1,492,000	—	31 Mar 2020	13F
State of New Jersey Common Pension Fund D	13F	Company	0.08%	226,775	$1,445,000	—	31 Mar 2020	13F
Swiss National Bank	13F	Company	0.08%	224,860	$1,432,000	—	31 Mar 2020	13F
DAVENPORT & Co LLC	13F	Company	0.06%	180,790	$1,152,000	—	31 Mar 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.06%	177,300	$1,129,000	—	31 Mar 2020	13F

Institutional Holders of SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) as of Q2 2020

As of 30 Jun 2020, SANGAMO THERAPEUTICS, INC - Common Stock (SGMO) was held by 197 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 77,064,448 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, WASATCH ADVISORS INC, STATE STREET CORP, Bellevue Group AG, CREDIT SUISSE AG/, DIMENSIONAL FUND ADVISORS LP, TWO SIGMA INVESTMENTS, LP, GEODE CAPITAL MANAGEMENT, LLC, and GOLDMAN SACHS GROUP INC. This page lists 197 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

175

Q2 2020 holders

197

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.